14-75963344-G-A
Variant summary
Our verdict is Pathogenic. The variant received 14 ACMG points: 14P and 0B. PM2PM5PP3_ModeratePP5_Very_Strong
The NM_003239.5(TGFB3):c.898C>T(p.Arg300Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000137 in 1,461,852 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R300Q) has been classified as Pathogenic.
Frequency
Consequence
NM_003239.5 missense
Scores
Clinical Significance
Conservation
Publications
- cranioectodermal dysplasia 3Inheritance: AR Classification: DEFINITIVE Submitted by: G2P
- short-rib thoracic dysplasia 18 with polydactylyInheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- cranioectodermal dysplasiaInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- ciliopathyInheritance: AR Classification: LIMITED Submitted by: Ambry Genetics
- retinitis pigmentosa 81Inheritance: AR, Unknown Classification: LIMITED Submitted by: Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 14 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_003239.5. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| TGFB3 | NM_003239.5 | MANE Select | c.898C>T | p.Arg300Trp | missense | Exon 5 of 7 | NP_003230.1 | ||
| TGFB3 | NM_001329939.2 | c.898C>T | p.Arg300Trp | missense | Exon 6 of 8 | NP_001316868.1 | |||
| TGFB3 | NM_001329938.2 | c.898C>T | p.Arg300Trp | missense | Exon 5 of 5 | NP_001316867.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| TGFB3 | ENST00000238682.8 | TSL:1 MANE Select | c.898C>T | p.Arg300Trp | missense | Exon 5 of 7 | ENSP00000238682.3 | ||
| TGFB3 | ENST00000556285.1 | TSL:1 | c.898C>T | p.Arg300Trp | missense | Exon 5 of 5 | ENSP00000451110.1 | ||
| TGFB3 | ENST00000556674.2 | TSL:3 | c.898C>T | p.Arg300Trp | missense | Exon 6 of 8 | ENSP00000502685.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 0.00000137 AC: 2AN: 1461852Hom.: 0 Cov.: 33 AF XY: 0.00000275 AC XY: 2AN XY: 727218 show subpopulations
Age Distribution
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Rienhoff syndrome Pathogenic:4
The following ACMG criteria were applied in classifying this variant: PS4, PM2, PM5_supp, PM6, PP3_strong, PP1_Strong
This sequence change replaces arginine, which is basic and polar, with tryptophan, which is neutral and slightly polar, at codon 300 of the TGFB3 protein (p.Arg300Trp). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with clinical features of Loeys-Dietz syndrome (PMID: 25835445, 31898322). In at least one individual the variant was observed to be de novo. ClinVar contains an entry for this variant (Variation ID: 203490). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed for this missense variant. However, the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on TGFB3 protein function. This variant disrupts the p.Arg300 amino acid residue in TGFB3. Other variant(s) that disrupt this residue have been observed in individuals with TGFB3-related conditions (PMID: 24798638, 26184463), which suggests that this may be a clinically significant amino acid residue. For these reasons, this variant has been classified as Pathogenic.
The variant is observed at an extremely low frequency in the gnomAD v4.0.0 dataset (total allele frequency: <0.001%). Predicted Consequence/Location: The majority of the known disease-causing variants of this gene are variants expected to result in premature termination of the protein. In silico tool predictions suggest damaging effect of the variant on gene or gene product [REVEL: 0.87 (>=0.6, sensitivity 0.68 and specificity 0.92); 3Cnet: 0.95 (>=0.6, sensitivity 0.72 and precision 0.9)]. The same nucleotide change resulting in the same amino acid change has been previously reported as pathogenic/likely pathogenic with strong evidence (ClinVar ID: VCV000203490 /PMID: 25835445). Different missense changes at the same codon (p.Arg300Gln, p.Arg300Gly) have been reported as pathogenic/likely pathogenic with strong evidence (ClinVar ID: VCV000143945 /PMID: 24798638, 26184463). Therefore, this variant is classified as Likely pathogenic according to the recommendation of ACMG/AMP guideline.
not provided Pathogenic:3
In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 25835445, 27848944, 29392890, 31898322)
Familial thoracic aortic aneurysm and aortic dissection Pathogenic:2
The p.R300W pathogenic mutation (also known as c.898C>T), located in coding exon 5 of the TGFB3 gene, results from a C to T substitution at nucleotide position 898. The arginine at codon 300 is replaced by tryptophan, an amino acid with dissimilar properties. This alteration is located in the latency-associated peptide domain and has been reported in individuals and families with hypertelorism, bifid uvula and/or cleft palate, and other overlapping Loeys-Dietz and Marfan syndrome-like features (Bertoli-Avella AM et al. J. Am. Coll. Cardiol., 2015 Apr;65:1324-36; Trujillano D et al. Eur. J. Hum. Genet., 2017 02;25:176-182; Schepers D et al. Hum. Mutat., 2018 May;39:621-634). Other substitutions at this amino acid position, p.R300Q and p.R300G, have been identified in families with similar clinical findings, as well as in an affected individual reported as a de novo case (Matyas G et al. Am. J. Med. Genet. A, 2014 Aug;164A:2141-3; Kuechler A et al. Mol. Cell. Probes, 2015 Oct;29:330-4). Internal structural analysis indicates that alterations at this position disrupt the putative furin pro-peptide cleavage motif of the protein (Dubois CM et al. J. Biol. Chem., 1995 May;270:10618-24; Lafyatis R. Nat Rev Rheumatol, 2014 Dec;10:706-19; Ambry internal data). Based on the supporting evidence, this alteration is interpreted as a disease-causing mutation.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at